Trial Radar AI
Clinical Trial NCT07158047 for Obesity (Disorder) is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Repeated Far Infrared Sauna Bathing in Adults With Obesity 20

Recruiting
Clinical Trial NCT07158047 is an interventional study for Obesity (Disorder) that is recruiting. It started on 7 March 2022 with plans to enroll 20 participants. Led by University of Oregon, it is expected to complete by 31 July 2026. The latest data from ClinicalTrials.gov was last updated on 4 March 2026.
Brief Summary
This is a clinical trial to determine if 30 sessions of far infrared sauna bathing can improve cardiovascular and metabolic function in adults with obesity.
Detailed Description
Obesity can increase the risk for cardiovascular and metabolic diseases. Lifestyle interventions are needed to reduce this risk. Far infrared saunas are one form of heat therapy that may help reduce these risks, however, there is limited research within a population with obesity. It is hypothesized that repeated far infrared sauna bathing will improve cardiovascular and metabolic function in adults with obesity.
Official Title

Targeting Hypertension and Insulin Resistance With Heat Therapy

Conditions
Obesity (Disorder)
Publications
Scientific articles and research papers published about this clinical trial:
Other Study IDs
  • 07312020.034
  • 19TPA34890033 (Other Grant/Funding Number) (American Heart Association)
NCT ID Number
NCT07158047
Start Date (Actual)
2022-03-07
Last Update Posted
2026-03-04
Completion Date (Estimated)
2026-07-31
Enrollment (Estimated)
20
Study Type
Interventional
PHASE
N/A
Status
Recruiting
Keywords
heat therapy
insulin resistance
arterial stiffness
blood pressure
obesity
sauna
vascular health
cardiovascular
metabolic function
Primary Purpose
Basic Science
Design Allocation
Randomized
Interventional Model
Parallel
Masking
None (Open Label)
Arms / Interventions
Participant Group/ArmIntervention/Treatment
ExperimentalHeat therapy
Group will undergo 30 sessions of heat therapy over approximately 10 weeks. Sessions will require participants to sit in a far infrared sauna for up to 45 min for 3 to 4 times per week.
Heat therapy
30 sessions of far infrared sauna bathing (45-60C) for up to 45 min
No InterventionTime control group
No participation in sauna bathing. Maintain lifestyle habits for approximately 10 weeks.
N/A
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Blood pressure change
Change in systolic and diastolic blood pressures after 30 sessions of Intervention
10 weeks
Blood glucose
Change in plasma glucose levels after Intervention
10 weeks
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Arterial stiffness reduction
Change in Carotid-femoral Pulse Wave Velocity (m/s) after Intervention
10 weeks
Serum insulin
Change in serum insulin levels after Intervention
10 weeks
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult
Minimum Age
18 Years
Eligible Sexes
All
  • BMI between 30-45 kg/m2

  • Diagnosed diabetes
  • Greater than stage 2 hypertension
  • Coagulopathies
  • Allergies to lidocaine
  • Medications affecting blood pressure
  • Blood clotting, and blood sugars
  • Smoker
  • Pregnant
  • Desiring to become pregnant in the near future
  • Breastfeeding
  • BMI less than 30
  • BMI greater than 45 kg/m2
  • Exercising > 120 min/week
  • Taking medications (other than hormone contraceptives)
  • Not willing to stop taking medications (other than hormone contraceptives) for 24 hours before testing days
University of Oregon logoUniversity of Oregon
Study Responsible Party
Christopher T Minson, PhD, Principal Investigator, Professor, University of Oregon
Study Central Contact
Contact: Christopher T Minson, PhD, 541-346-7583, [email protected]
Contact: John R Halliwill, PhD, 541-346-7591, [email protected]
1 Study Locations in 1 Countries

Oregon

University of Oregon, Eugene, Oregon, 97401, United States
Christopher T Minson, PhD, Contact, 5413467583, [email protected]
John R Halliwill, PhD, Contact, 5413467591, [email protected]
Christopher T Minson, PhD, Principal Investigator
Recruiting